Healthcor Management Initiates Exposure to Oxygen Biotherapeutics, Inc. (OXBT)

Arthur Cohen and Joseph Healey‘s Healthcor Management has added Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) to its equity portfolio. The fund revealed holding 1.5 million shares of the company, the stake being equal to 5.39% of the outstanding stock.

Arthur B Cohen and Joseph Healey

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)s is a small cap healthcare company engaged in developing biotechnology products related to oxygen delivery to tissue. Its stock has gained around 24% since the beginning of the year. For the last quarter of 2013, the company reported a net loss of $0.86 per diluted share, narrowing the loss from $1.45 per share reported for the previous quarter. For 2014, analysts expect the company to deliver a net loss of -$0.87 per share.

Aside from Healthcor, another investor, that has started a stake in Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) recently, is Hal Mintz‘ Sabby Management. Sabby reported, earlier this month, holding more than 1.96 million shares of the company, which represent 7.43% of the outstanding stock. Ellington, managed by Mike Vranos, has also added the company to its equity portfolio during the last quarter of 2013, although it holds a less significant stake, which contains just 34,200 shares.

Earlier this year, Healthcor Management, reported boosting its position in another small-cap healthcare company, CareView Communications Inc (OTCBB:CRVW). In two filings, Healthcor disclosed raising its holding to 39.13 million shares, and then to 55.63 million, which represent 28.6% of the outstanding stock.

Healthcare stocks amass the largest portion of Healthcor’s $1.65 billion equity portfolio. The fund holds the largest position in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX): 10.00 million shares, worth $154.6 million. McKesson Corporation (NYSE:MCK) is the next largest holding, which has been raised by 250% over the quarter to 600,000 shares; followed by Cubist Pharmaceuticals Inc (NASDAQ:CBST), in which the fund owns 1.4 million shares.

Disclosure: none

Recommended Reading:

David Einhorn, Greenlight Capital Raise Stake in BioFuel Energy Corp. (BIOF); Send Business Proposal To Board

Wexford Capital Reveals New Position in Famous Dave’s of America, Inc.(DAVE)

Leon Cooperman is Bullish on London-listed Monitise Plc (MONI) and Raises Stake to 10.9%


Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!